•   
  •   

Health & Fitness PROF BRENDAN WREN: There is nothing to fear from the Covid vaccine

03:25  25 november  2020
03:25  25 november  2020 Source:   dailymail.co.uk

Coronavirus vaccine may not be ready for the public until NEXT winter

  Coronavirus vaccine may not be ready for the public until NEXT winter Professor Peter Openshaw, from Imperial College London, warned that there could be a lag of at least nine months between a vaccine being discovered and production being scaled up.Professor Peter Openshaw, from Imperial College London and an advisor to the Government's Scientific Advisory Group for Emergencies, said he expected a nine-month gap between the vaccine's discovery and it being made available to the public.

Prof . Haseltine also argues that the trials have all been “designed to succeed.” There are very good reasons for this rush, but I advise caution. Should everyone take the vaccine ? Probably yes for those at highest risk of serious infection and death, where the potential benefit is high.

But nothing can happen until the vaccine has been approved by regulators who will assess the vaccine 's safety, effectiveness, and that it There were no Covid hospitalisations or deaths in people who got the Oxford vaccine ." Dr Stephen Griffin, from the University of Leeds, said: "This is yet more

MailOnline logo © Provided by Daily Mail MailOnline logo

Only a few months ago, as the Covid-19 pandemic continued to rage, some pessimistic experts were claiming that we would ‘just have to learn to live with the virus’.

But Christmas has arrived early. After months of locked-down misery, the best gift we could have is the news that scientists have developed several effective anti-Covid vaccines.

Judging by the success of the trials, we will soon have the means not just to provide protection against the virus, but even to stop its transmission.

a man holding his hand up: Judging by the success of the trials, we will soon have the means not just to provide protection against the virus, but even to stop its transmission © Provided by Daily Mail Judging by the success of the trials, we will soon have the means not just to provide protection against the virus, but even to stop its transmission

Once an immunisation programme is fully under way early next year, society really can begin to return to normal.

When should we start testing COVID-19 vaccines in kids?

  When should we start testing COVID-19 vaccines in kids? A vaccine cannot be approved for use in kids until vaccine trials with young participants are complete. Bacteria and viruses that are deadly to one type of creature can evolve quickly to infect another. While the new coronavirus SARS-CoV-2 (which causes COVID-19) is the latest example, a host of infectious and deadly diseases have hopped from animals to humans and even from humans to animals.

Early results from trials of a Covid vaccine developed in Russia suggest it could be 92% effective. So far there are no safety issues, with Russian researchers saying there were "no unexpected adverse events" 21 days after volunteers received their first of two injections.

A vial containing a Russian Covid -19 vaccine undergoing human trials © Russian Defense Ministry / RIA Novosti. Like their colleagues in the world's other leading nations, Russian scientists have traveled a bumpy road from the discovery of coronavirus to the development of a promising vaccine

Thanks to the work of Pfizer, Moderna and the Oxford-AstraZeneca partnership —which this week revealed that, in preliminary tests, its vaccine achieved an efficacy rate of up to 90 per cent, depending on the size of the dosage — freedom from the menace of Covid now beckons.

Their success is certain to be followed by other vaccines, such as Russia’s Sputnik V programme, which released data yesterday suggesting it is ‘more than 95 per cent effective’ — the threshold reached by Pfizer and Moderna. We have yet to hear about China’s vaccination efforts.

But despite this flood of welcome news, I know many people feel concerned about the safety of these vaccines, and not least the speed with which they have been developed.

Their anxiety may be deepened by reports that the Oxford-AstraZeneca vaccine uses a genetically modified adenovirus that gives a version of the common cold to chimpanzees.

Drinking tea can significantly lower blood pressure

 Drinking tea can significantly lower blood pressure © wenn A new study has found that drinking tea can significantly lower blood pressure. Researchers at the University of Reading and Cambridge University have found that foods and drinks such as tea, apples and berries are high in flavonoids, and may reduce the risk of high blood pressure. High blood pressure can increase the chances of being diagnosed with a serious disease, such as coronary heart disease or kidney disease, if left untreated.

But it showed us that we could make a vaccine with this technology that would induce good immune responses against a coronavirus spike protein. The bulk of the vaccine rollout programme will be in January, February, March, and we hope that sometime after Easter things will be able to start to get

As most of us obsess with avoiding Covid -19 at all costs, a rapidly growing group of people around the world say they are prepared to deliberately take on the virus.

Such adenoviruses are not remotely dangerous and cannot cause disease in humans, but such terminology conjures up images of sinister biological manipulation.

Others may baulk at the fact that while many of the most common vaccines in use took decades to develop, refine and gain regulatory approval, we have an abundance of jabs less than a year after the first cases of Covid-19 emerged. Have corners been cut? Has the usual scrutiny of new medicines been abandoned?

As a specialist in this field, I can allay all such fears. The development of these vaccines has not been dangerously rushed. No risks or shortcuts with safety have been taken.

For those who worry that something could suddenly go wrong in two years’ time, rest assured that everything we know about vaccines means that such a scenario is most statistically unlikely.

The trials have been thorough, involving more than 100,000 volunteers, among them some of my colleagues here at the London School of Hygiene & Tropical Medicine.

Only a 'small chance' of a Covid-19 vaccine by Xmas: Oxford

  Only a 'small chance' of a Covid-19 vaccine by Xmas: Oxford Oxford University's Professor Andrew Pollard poured cold water on the idea a vaccine could be rolled out by the end of the year. As did Kate Bingham, the UK's vaccine tsar.Professor Andrew Pollard said he was optimistic data showing his team's vaccine works and is safe will be available by the end of the year.

How good is the Oxford/AstraZeneca Covid vaccine ? At the heart of the Oxford/AstraZeneca vaccine is a virus that causes the common cold in chimpanzees. The chimp virus is modified so it cannot multiply and cause disease in the body.

In France, for example, little more than half of adults plan to get vaccinated against COVID -19, according to a recent survey. View on euronews.

Those individuals — vaccine experts — are unlikely to have volunteered to take part if they had serious doubts about safety and they can testify to the efficiency of the trials.

Some might argue a sample of even 100,000 people is too small for problems to show up. When vaccination is scaled up, with tens of millions of people in this country — and billions around the world — receiving the jabs, aren’t we more likely to see side-effects emerge?

The truth is that both the number and diversity of the volunteers in current vaccine trials is easily large enough in statistical terms to draw firm conclusions.

The Oxford-AstraZeneca team says it can manufacture 40 million doses for this country by early in the new year, making a rapid mass-vaccination programme highly feasible and relatively cheap © Provided by Daily Mail The Oxford-AstraZeneca team says it can manufacture 40 million doses for this country by early in the new year, making a rapid mass-vaccination programme highly feasible and relatively cheap

And while the Covid vaccines have been developed far faster than is usual, there are three very good reasons for that.


Gallery: 20 early symptoms of dementia (Espresso)

a man standing on top of a grass covered field: Cognitive decline becomes classified as dementia when it is severe enough to interfere with daily life and activities. Alzheimer’s disease, for instance, one of the most widespread forms of dementia, causes brain cell function to deteriorate. Would you be able to recognize the symptoms of this creeping affliction? Keep reading to explore the subtle signs of dementia, which tends to worsen as you age.

First, the scale of the threat acted as a tremendous catalyst for swift action, encouraging innovation, ingenuity and creativity — just as World War II fostered pioneering inventions such as the jet engine, radar and computers.

'Great day for humanity': Pfizer says COVID-19 vaccine over 90% effective

  'Great day for humanity': Pfizer says COVID-19 vaccine over 90% effective Hilaria Baldwin has called time on having more children with her husband Alec Baldwin, announcing her fifth baby was her last.

Second, scientists from around the world have co-operated to an unprecedented degree, speeding up research.

Once China started sharing its vital data on the DNA sequence of the new coronavirus, researchers were swiftly able to identify its ‘spike protein’ and develop targeted measures to counter it.

Third, there have been tremendous leaps in the development of vaccines in recent years, especially in the wake of the SARS and MERS epidemics — both strains of coronavirus — that struck Asia and the Middle East in 2002 and 2012 respectively.

From the off, our fight against Covid-19 was built on that springboard of knowledge.

The Oxford-AstraZeneca team adopted the ‘traditional’ approach of using a harmless, weakened virus (that chimp ‘cold’ virus) to deliver spike protein to trigger the body’s immune system to protect from future infection.

In contrast, Pfizer and Moderna used the more novel method of ‘messenger RNA’ (ribonucleic acid — the genetic material of the coronavirus), causing the production of viral proteins in the body which spark the immune system to create antibodies and T-cells to combat the virus.

a person standing in a room: Both types of vaccine are safe and I would be happy to have either. There is no evidence of any serious side-effects from any of the vaccines and I seriously doubt any will emerge © Provided by Daily Mail Both types of vaccine are safe and I would be happy to have either. There is no evidence of any serious side-effects from any of the vaccines and I seriously doubt any will emerge

But we should not exaggerate the novelty of messenger RNA. It has been used in potential vaccines for decades, and scientists understand it well.

The UK vaccination and immunisation schedule: when to vaccinate your kids

  The UK vaccination and immunisation schedule: when to vaccinate your kids Expert advice on childhood vaccinations in the UK, including side-effects and benefits.Here is everything you need to know about the the latest vaccine schedule for your children, as well as the benefits of immunisation and any potential side-effects you should be aware of:

To be clear: both types of vaccine are safe and I would be happy to have either. There is no evidence of any serious side-effects from any of the vaccines and I seriously doubt any will emerge.

But if I were forced to make a choice, I would go for the Oxford-AstraZeneca, because it uses the most tried and tested of vaccine delivery systems. I would certainly have no worries about its association with chimpanzees.

Russian propaganda on social media about the Oxford vaccine ‘turning humans into monkeys’ is a crude, laughable attempt to spook us — and how ironic that Russia’s Sputnik V vaccine uses the same delivery system!

Such lurid disinformation should be treated with the contempt it deserves.

graphical user interface, application: After months of locked-down misery, the best gift we could have is the news that scientists have developed several effective anti-Covid vaccines © Provided by Daily Mail After months of locked-down misery, the best gift we could have is the news that scientists have developed several effective anti-Covid vaccines

The Oxford vaccine has two other crucial advantages. First, it is much cheaper to produce, with each jab costing just £3, compared with at least £15 for the other vaccines. Low cost is essential as we need a global solution to a global problem.

The Oxford-AstraZeneca team says it can manufacture 40 million doses for this country by early in the new year, making a rapid mass-vaccination programme highly feasible and relatively cheap. Second, its vaccine can be stored in a fridge, while Pfizer’s must be kept below minus 70c (minus 94f) in specialist freezers.

I understand that despite all my reassurances about safety, some parents may see no need for jabs to be administered to their own children. After all, youngsters rarely suffer any symptoms of Covid but may feel the side-effects — even mild ones — of a vaccination.

Children will probably be the last to receive the vaccine. But they should not be ignored altogether because they can still spread the virus.

Whatever the benefits, it would be wrong for vaccination to become compulsory.

It might be that international travel and attendance at mass events such as concerts or football matches require a ‘certificate of immunity’, but that sort of curtailment of liberty should not become universal.

Nor should freedom of speech be restricted by criminalising anti-vaccination material online or elsewhere. The best way to deal with the anti-vaxxers is not to make them martyrs by trying to silence them, but to challenge their empty arguments.

Let the results of the vaccines be the best weapon in the campaign for their acceptance.

And with each passing day, those results are looking more and more impressive.

Read more

Real thing or placebo? My COVID-19 vaccine odyssey continues .
Real thing or placebo? My COVID-19 vaccine odyssey continuesLONDON (Reuters) - The subject line on the email I received last week said simply, "Test.

usr: 2
This is interesting!